Strafford will be offering a webinar entitled "Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment" on January 5, 2023 from 1:00 to 2:30 pm (EST). Mark J. Feldstein, Alissa K. Lipton, Amanda K. Murphy, William B. Raich, and Yieyie Yang of Finnegan Henderson Farabow Garrett & Dunner will guide attendees on the Biologics Price Competition and Innovation Act (BPCIA), discuss the Purple Book and issues related to exclusivities and the retroactivity of the BPCIA, address the ongoing debate over whether the BPCIA's patent dispute resolution procedures are allowed or required and the litigation that has followed, and look back at the 12 years of the BPCIA and discuss where things are going. The webinar will review the following issues:
• What the Purple Book and the new transparency requirements mean for biologics companies
• How the courts are treating BPCIA issues
• Implications of the potential unavailability of IPR and PGR for biosimilars
The registration fee for the webcast is $347. Those interested in registering for the webinar, can do so here.
Comments